Managing occupational risks for hepatitis C transmission in the health care setting

Clinical Microbiology Reviews

Volumn 16, Issue 3, 2003, Pages 546-568

  Henderson, David K ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b Building 10 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; HEPATITIS C VACCINE; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT;

DRUG EFFICACY; DRUG SAFETY; FLAVIVIRUS; HEALTH CARE PERSONNEL; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK POPULATION; HOSPITAL INFECTION; HUMAN; IMMUNOPATHOLOGY; INFECTION CONTROL; INFECTION RISK; NONHUMAN; OCCUPATIONAL DISEASE; OCCUPATIONAL EXPOSURE; PREVALENCE; PRIMARY PREVENTION; PROPHYLAXIS; REVIEW; UNITED STATES; VIRUS TRANSMISSION;

DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL; DISEASE TRANSMISSION, PROFESSIONAL-TO-PATIENT; HEALTH PERSONNEL; HEPATITIS C; HUMANS; OCCUPATIONAL DISEASES; RISK;

FLAVIVIRUS; HEPATITIS C VIRUS; RNA VIRUSES;

EID: 0038107637     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.16.3.546-568.2003     Document Type: Review

References (380)

1. Abacioglu, Y. H., F. Bacaksiz, I. H. Bahar, and P. Simmonds. 2000. Molecular evidence of nosocomial transmission of hepatitis C virus in a haemodialysis unit. Eur. J. Clin. Microbiol. Infect. Dis. 19:182-186.
2. Abel, S., R. Cesaire, D. Cales-Quist, O. Bera, G. Sobesky, and A. Cabie. 2000. Occupational transmission of human immunodeficiency virus and hepatitis C virus after a punch. Clin. Infect. Dis. 31:1494-1495.
3. Ackerman, Z., E. Ackerman, and O. Paltiel. 2000. Intrafamilial transmission of hepatitis C virus: a systematic review. J. Viral Hepatol. 7:93-103.
4. Akahane, Y., M. Kojima, Y. Sugai, M. Sakamoto, Y. Miyazaki, T. Tanaka, F. Tsuda, S. Mishiro, H. Okamoto, Y. Miyakawa, et al. 1994. HCV infection in spouses of patients with type C chronic liver disease. Ann. Intern. Med. 120:748-752.
5. Alain, S., V. Loustaud-Ratti, F. Dubois, M. D. Bret, S. Rogez, E. Vidal, and F. Denis. 2002. Seroreversion from hepatitis C after needle stick injury. Clin. Infect. Dis. 34:717-719.
6. Alberti, A., S. Boccato, A. Vario, and L. Benvegnu. 2002. Therapy of acute hepatitis C. Hepatology 36:S195-200.
7. Alfurayh, O., A. Sabeel, M. N. Al Ahdal, K. Almeshari, G. Kessie, M. Hamid, and D. M. Dela Cruz. 2000. Hand contamination with hepatitis C virus in staff looking after hepatitis C-positive hemodialysis patients. Am. J. Nephrol. 20:103-106.
8. Allander, T., A. Gruber, M. Naghavi, A. Beyene, T. Soderstrom, M. Bjorkholm, L. Grillner, and M. A. Persson. 1995. Frequent patient-to-patient transmission of hepatitis C virus in a haematology ward. Lancet 345:603-607.
9. Allander, T., C. Medin, S. H. Jacobson, L. Grillner, and M. A. Persson. 1996. Transmission of hepatitis C virus by transfer of an infected individual to a new dialysis unit. Nephron 73:110.
10. Allory, Y., F. Charlotte, Y. Benhamou, P. Opolon, Y. Le Charpentier, and T. Poynard. 2000. Impact of human immunodeficiency virus infection on the histological features of chronic hepatitis C: a case-control study. The MULTIVIRC group. Hum. Pathol. 31:69-74.
11. Alter, H. J. 1991. Descartes before the horse: I clone, therefore I am: the hepatitis C virus in current perspective. Ann. Intern. Med. 115:644-649.
12. Alter, H. J., C. Conry-Cantilena, J. Melpolder, D. Tan, M. Van Raden, D. Herion, D. Lau, and J. H. Hoofnagle. 1997. Hepatitis C in asymptomatic blood donors. Hepatology 26:29S-33S.
13. Alter, H. J., R. H. Purcell, J. W. Shih, J. C. Melpolder, M. Houghton, Q. L. Choo, and G. Kuo. 1989. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N. Engl. J. Med. 321:1494-1500.
14. Alter, M. J. 1999. HCV infection in the United States. J. Hepatol. 31(Suppl. 1):88-91.
15. Alter, M. J., D. Kruszon-Moran, O. V. Nainan, G. M. McQuillan, F. Gao, L. A. Moyer, R. A. Kaslow, and H. S. Margolis. 1999. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N. Engl. J. Med. 341:556-562.
16. Alter, M. J., E. E. Mast, L. A. Moyer, and H. S. Margolis. 1998. Hepatitis C. Infect. Dis. Clin. North Am. 12:13-26.
17. Alvarado-Ramy, F., M. J. Alter, W. Bower, D. K. Henderson, A. H. Sohn, R. L. Sinkowitz-Cochran, and W. R. Jarvis. 2001. Management of occupational exposures to hepatitis C virus: current practice and controversies. Infect. Control Hosp. Epidemiol. 22:53-55.
18. Arai, Y., K. Noda, N. Enomoto, K. Arai, Y. Yamada, K. Suzuki, and H. Yoshihara. 1996. A prospective study of hepatitis C virus infection after needle stick accidents. Liver 16:331-334.
19. Armstrong, G. L., M. J. Alter, G. M. McQuillan, and H. S. Margolis. 2000. The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States. Hepatology 31:777-782.
20. Asti, M., M. Martinetti, C. Zavaglia, M. C. Cuccia, L. Gusberti, C. Tinelli, A. Cividini, S. Bruno, L. Salvaneschi, G. Ideo, M. U. Mondelli, and E. M. Silini. 1999. Human leukocyte antigen class II and III alleles and severity of hepatitis C virus-related chronic liver disease. Hepatology 29:1272-1279.
21. Aucella, F., M. Vigilante, G. L. Valente, and C. Stallone. 2000. Systematic monitor disinfection is effective in limiting HCV spread in hemodialysis. Blood Purif. 18:110-114.
22. Baldo, V., A. Floreani, L. Dal Vecchio, M. Cristofoletti, M. Carletti, S. Majori, A. Di Tommaso, and R. Trivello. 2002. Occupational risk of blood-borne viruses in healthcare workers: a 5-year surveillance program. Infect. Control Hosp. Epidemiol. 23:325-327.
23. Bari, A., S. Akhtar, M. H. Rahbar, and S. P. Luby. 2001. Risk factors for hepatitis C virus infection in male adults in Rawalpindi-Islamabad, Pakistan. Trop. Med. Int. Health 6:732-738.
24. Barrett, S., E. Ryan, and J. Crowe. 1999. Association of the HLA-DRB1*01 allele with spontaneous viral clearance in an Irish cohort infected with hepatitis C virus via contaminated anti-D immunoglobulin. J. Hepatol. 30:979-983.
25. Bassett, S. E., D. L. Thomas, K. M. Brasky, and R. E. Lanford. 1999. Viral persistence, antibody to E1 and E2, and hypervariable region 1 sequence stability in hepatitis C virus-inoculated chimpanzees. J. Virol. 73:1118-1126.
26. Beekmann, S. E., D. Vlahov, D. E. Koziol, E. D. McShalley, J. M. Schmitt, and D. K. Henderson. 1994. Temporal association between implementation of universal precautions and a sustained, progressive decrease in percutaneous exposures to blood. Clin. Infect. Dis. 18:562-569.
27. Bell, D. M., C. N. Shapiro, D. H. Culver, W. J. Martone, J. W. Curran, and J. M. Hughes. 1992. Risk of hepatitis B and human immunodeficiency virus transmission to a patient from an infected surgeon due to percutaneous injury during an invasive procedure: estimates based on a model. Infect. Agents Dis. 1:263-269.
28. Reference deleted.
29. Beltrami, E. M., I. T. Williams, C. N. Shapiro, and M. E. Chamberland. 2000. Risk and management of blood-borne infections in health care workers. Clin. Microbiol. Rev. 13:385-407.
30. Benhamou, Y., M. Bochet, V. Di Martino, F. Charlotte, F. Azria, A. Coutellier, M. Vidaud, F. Bricaire, P. Opolon, C. Katlama, and T. Poynard. 1999. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology 30:1054-1058.
31. Benitez Rodriguez, E., A. J. Ruiz Moruno, J. A. Cordoba Dona, A. Escolar Pujolar, and F. J. Lopez Fernandez. 1999. Underreporting of percutaneous exposure accidents in a teaching hospital in Spain. Clin. Perform. Qual. Health Care 7:88-91.
32. Bjorkander, J., A. Fasth, and A. Widell. 1996. Intravenous immunoglobulin and hepatitis C virus: the Scandinavian experience. Clin. Ther. 18:73-82.
33. Bonacini, M., and M. Puoti. 2000. Hepatitis C in patients with human immunodeficiency virus infection: diagnosis, natural history, meta-analysis of sexual and vertical transmission, and therapeutic issues. Arch. Intern. Med. 160:3365-3373.
34. Bonkovsky, H. L., and S. Mehta. 2001. Hepatitis C: a review and update. Dis. Mon 47:610-647.
35. Bosch, X. 1998. Hepatitis C outbreak astounds Spain. Lancet 351:1415.
36. Bosch, X. 2000. Newspaper apportions blame in Spanish hepatitis C scandal. Lancet 355:818.
37. Brenner, B. 1996. Clinical experience with Octagam, a solvent detergent (SD) virus inactivated intravenous gammaglobulin. Clin. Exp. Rheumatol. 14:S115-S119.
38. Bresee, J. S., E. E. Mast, P. J. Coleman, M. J. Baron, L. B. Schonberger, M. J. Alter, M. M. Jonas, M. Y. Yu, P. M. Renzi, and L. C. Schneider. 1996. HCV infection associated with administration of intravenous immune globulin. A cohort study. JAMA 276:1563-1567.
39. Brettler, D. B., P. M. Mannucci, A. Gringeri, J. E. Rasko, A. D. Forsberg, M. G. Rumi, R. J. Garsia, K. A. Rickard, and M. Colombo. 1992. The low risk of hepatitis C virus transmission among sexual partners of hepatitis C-infected hemophilic males: an international, multicenter study. Blood 80:540-543.
40. Bronowicki, J. P., V. Venard, C. Botte, N. Monhoven, I. Gastin, L. Chone, H. Hudziak, B. Rihn, C. Delanoe, A. LeFaou, M. A. Bigard, P. Gaucher, and B. Rhin. 1997. Patient-to-patient transmission of hepatitis C virus during colonoscopy. N. Engl. J. Med. 337:237-240.
41. Brown, P. 1999. Surgeon infects patient with hepatitis C. Br. Med. J. 319:1219.
42. Busch, M. P. 2001. Insights into the epidemiology, natural history and pathogenesis of hepatitis C virus infection from studies of infected donors and blood product recipients. Transfus. Clin. Biol. 8:200-206.
43. Cabrera Chaves, T., M. A. Simon Marco, F. Gomollon Garcia, M. T. Botella Esteban, and R. Uribarrena Echebarria. 1996. Hepatitis C following administration of intravenous immunoglobulins. Gastroenterol. Hepatol. 19:305-308.
44. Calleri, G., P. Colombatto, M. Gozzelino, F. Chieppa, P. Romano, B. Delmastro, A. Macor, G. Cariti, M. R. Brunetto, W. Grillone, and F. Bonino. 1998. Natural beta interferon in acute type-C hepatitis patients: a randomized controlled trial. Ital. J. Gastroenterol. Hepatol. 30:181-184.
45. Cardo, D. M., D. H. Culver, C. A. Ciesielski, P. U. Srivastava, R. Marcus, D. Abiteboul, J. Heptonstall, G. Ippolito, F. Lot, P. S. McKibben, D. M. Bell, and the CDC Needle Stick Surveillance Group. 1997. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. N. Engl. J. Med. 337:1485-1490.
46. Cariani, E., A. Zonaro, D. Primi, E. Magni, C. Incarbone, P. Scalia, E. Tanzi, G. Zehender, and A. R. Zanetti. 1991. Detection of HCV RNA and antibodies to HCV after needle stick injury. Lancet 337:850.
47. Carreno, V. 2002. Present treatment expectations and risks of chronic hepatitis C. Clin. Microbiol. Infect. 8:74-79.
48. Casino, C., J. McAllister, F. Davidson, J. Power, E. Lawlor, P. L. Yap, P. Simmonds, and D. B. Smith. 1999. Variation of hepatitis C virus following serial transmission: multiple mechanisms of diversification of the hypervariable region and evidence for convergent genome evolution. J. Gen. Virol. 80:717-725.
49. Centers for Disease Control. 1991. Recommendations for preventing transmission of human immunodeficiency virus and hepatitis B virus to patients during exposure-prone invasive procedures. Morb. Mortal. Wkly. Rep. 40:1-9.
50. Centers for Disease Control. 1987. Recommendations for prevention of HIV transmission in health-care settings. Morb. Mortal. Wlky. Rep. 36:1S-19S.
51. Centers for Disease Control. 1988. Update: universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other blood-borne pathogens in health-care settings. Morb. Mortal. Wkly. Rep. 37:377-382, 387-388.
52. Centers for Disease Control and Prevention. 1994. Outbreak of hepatitis C associated with intravenous immunoglobulin administration-United States, October 1993-June 1994. Morb. Mortal. Wkly. Rep. 43:505-509.
53. Centers for Disease Control and Prevention. 1998. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention. Morb. Mortal. Wkly. Rep. 47:1-39.
54. Centers for Disease Control and Prevention. 1997. Transmission of hepatitis C virus infection associated with home infusion therapy for hemophilia. Morb. Mortal. Wkly. Rep. 46:597-599.
55. Centers for Disease Control and Prevention. 2001. Updated U.S. Public Health Service guidelines for the management of occupational exposures to hepatitis B virus, HCV, and HIV and recommendations for postexposure prophylaxis. Morb. Mortal. Wlky. Rep. 50:1-52.
56. Cerrai, T., S. Michelassi, C. Ierpi, G. Toti, A. L. Zignego, and M. Lombardi. 1998. Universal precautions and dedicated machines as cheap and effective measures to control HCV spread. Edtna Erca J. 24:43-45, 48.
57. Chander, G., M. S. Sulkowski, M. W. Jenckes, M. S. Torbenson, H. F. Herlong, E. B. Bass, and K. A. Gebo. 2002. Treatment of chronic hepatitis C: a systematic review. Hepatology 36:S135-S144.
58. Chandra, S., J. E. Cavanaugh, C. M. Lin, C. Pierre-Jerome, N. Yerram, R. Weeks, E. Flanigan, and F. Feldman. 1999. Virus reduction in the preparation of intravenous immune globulin: in vitro experiments. Transfusion 39:249-257.
59. Chang, K. M., R. Thimme, J. J. Melpolder, D. Oldach, J. Pemberton, J. Moorhead-Loudis, J. G. McHutchison, H. J. Alter, and F. V. Chisari. 2001. Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection. Hepatology 33:267-276.
60. Chang, T. T., T. C. Liou, K. C. Young, X. Z. Lin, C. Y. Lin, J. S. Shin, and H. L. Wu. 1994. Intrafamilial transmission of hepatitis C virus: the important role of inapparent transmission. J. Med. Virol. 42:91-96.
61. Chapel, H. M., J. M. Christie, V. Peach, and R. W. Chapman. 2001. Five-year follow-up of patients with primary antibody deficiencies following an outbreak of acute hepatitis C. Clin. Immunol. 99:320-324.
62. Chayama, K., M. Kobayashi, A. Tsubota, I. Koida, Y. Arase, S. Saitoh, K. Ikeda, and H. Kumada. 1995. Molecular analysis of intraspousal transmission of hepatitis C virus. J. Hepatol. 22:431-439.
63. Cheung, R. C. 2000. Epidemiology of hepatitis C virus infection in American veterans. Am. J. Gastroenterol. 95:740-747.
64. Choo, Q. L., G. Kuo, A. Weiner, K. S. Wang, L. Overby, D. Bradley, and M. Houghton. 1992. Identification of the major, parenteral non-A, non-B hepatitis agent (hepatitis C virus) using a recombinant cDNA approach. Semin. Liver Dis. 12:279-288.
65. Choo, Q. L., G. Kuo, A. J. Weiner, L. R. Overby, D. W. Bradley, and M. Houghton. 1989. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359-362.
66. Choo, Q. L., K. H. Richman, J. H. Han, K. Berger, C. Lee, C. Dong, C. Gallegos, D. Coit, R. Medina-Selby, P. J. Barr, et al. 1991. Genetic organization and diversity of the hepatitis C virus. Proc. Natl. Acad. Sci. USA 88:2451-2455.
67. Choo, Q. L., A. J. Weiner, L. R. Overby, G. Kuo, M. Houghton, and D. W. Bradley. 1990. HCV: the major causative agent of viral non-A, non-B hepatitis. Br. Med. Bull. 46:423-441.
68. Christie, J. M., C. J. Healey, J. Watson, V. S. Wong, M. Duddridge, N. Snowden, W. M. Rosenberg, K. A. Fleming, H. Chapel, and R. W. Chapman. 1997. Clinical outcome of hypogammaglobulinaemic patients following outbreak of acute hepatitis C: 2 year follow up. Clin. Exp. Immunol. 110:4-8.
69. Cividini, A., C. Rebucci, E. Silini, and M. U. Mondelli. 2001. Is the natural history of hepatitis C virus carriers with normal aminotransferase really benign? Gastroenterology 121:1526-1527.
70. Cockcroft, A. 2000. Surgeons who test positive for hepatitis C should not be transferred to low risk duties. Rev. Med. Virol. 10:79-82.
71. Cody, S. H., O. V. Nainan, R. S. Garfein, H. Meyers, B. P. Bell, C. N. Shapiro, E. L. Meeks, H. Pitt, E. Mouzin, M. J. Alter, H. S. Margolis, and D. J. Vugia. 2002. HCV transmission from an anesthesiologist to a patient. Arch. Intern. Med. 162:345-350.
72. Conry-Cantilena, C., M. VanRaden, J. Gibble, J. Melpolder, A. O. Shakil, L. Viladomiu, L. Cheung, A. DiBisceglie, J. Hoofnagle, J. W. Shih, et al. 1996. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N. Engl. J. Med. 334:1691-1696.
73. Cooper, B. W., A. Krusell, R. C. Tilton, R. Goodwin, and R. E. Levitz. 1992. Seroprevalence of antibodies to hepatitis C virus in high-risk hospital personnel. Infect. Control Hosp. Epidemiol. 13:82-85.
74. Cooper, S., A. L. Erickson, E. J. Adams, J. Kansopon, A. J. Weiner, D. Y. Chien, M. Houghton, P. Parham, and C. M. Walker. 1999. Analysis of a successful immune response against hepatitis C virus. Immunity 10:439-449.
75. Cramp, M. E., P. Carucci, S. Rossol, S. Chokshi, G. Maertens, R. Williams, and N. V. Naoumov. 1999. HCV (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia. Gut 44:424-429.
76. Cramp, M. E., P. Carucci, J. Underhill, N. V. Naoumov, R. Williams, and P. T. Donaldson. 1998. Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia. J. Hepatol. 29:207-213.
77. Davis, G. L. 2001. Current treatment for chronic hepatitis C. Rev. Gastroenterol. Disord. 1:59-72.
78. Delarocque-Astagneau, E., N. Baffoy, V. Thiers, N. Simon, H. de Valk, S. Laperche, A. M. Courouce, P. Astagneau, C. Buisson, and J. C. Desenclos. 2002. Outbreak of hepatitis C virus infection in a hemodialysis unit: potential transmission by the hemodialysis machine? Infect. Control Hosp. Epidemiol. 23:328-334.
79. Department of Health. 14 August 2002, posting date. Hepatitis C infected health care workers, implementing getting ahead of the curve: action on blood-borne viruses. Department of Health, London, United Kingdom, (Online.)
80. Department of Health. 14 August 2002, posting date. Hepatitis infected health care workers. Health Service Circular HSC 2002/010. Department of Health, London, United Kingdom. (Online.)
81. Desenclos, J. C., M. Bourdiol-Razes, B. Rolin, P. Garandeau, J. Ducos, C. Brechot, and V. Thiers. 2001. Hepatitis C in a ward for cystic fibrosis and diabetic patients: possible transmission by spring-loaded finger-stick devices for self-monitoring of capillary blood glucose. Infect. Control Hosp. Epidemiol. 22:701-707.
82. Di Bisceglie, A. M., and J. H. Hoofnagle. 2002. Optimal therapy of hepatitis C. Hepatology 36:S121-S127.
83. Diepolder, H. M., R. M. Hoffmann, J. T. Gerlach, R. Zachoval, M. C. Jung, and G. R. Pape. 1998. Immunopathogenesis of HCV infection. Curr. Stud. Hematol. Blood Transfus. :135-151.
84. Diepolder, H. M., M. C. Jung, E. Keller, W. Schraut, J. T. Gerlach, N. Gruner, R. Zachoval, R. M. Hoffmann, C. A. Schirren, S. Scholz, and G. R. Pape. 1998. A vigorous virus-specific CD4+ T-cell response may contribute to the association of HLA-DR13 with viral clearance in hepatitis B. Clin. Exp. Immunol. 113:244-251.
85. Diepolder, H. M., R. Zachoval, R. M. Hoffmann, E. A. Wierenga, T. Santantonio, M. C. Jung, D. Eichenlaub, and G. R. Pape. 1995. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 346:1006-1007.
86. Di Nardo, V., M. E. Bonaventura, B. Chiaretti, N. Petrosillo, V. Puro, and G. Ippolito. 1994. Low risk of HCV infection in health care workers. Infection 22:115.
87. Di Stefano, R., T. Stroffolini, D. Ferraro, A. Usticano, L. M. Valenza, L. Montalbano, G. Pomara, and A. Craxi. 2002. Endemic hepatitis C virus infection in a Sicilian town: further evidence for iatrogenic transmission. J. Med. Virol. 67:339-344.
88. Djordjevic, V., K. Stojanovic, M. Stojanovic, and V. Stefanovic. 2000. Prevention of nosocomial transmission of hepatitis C infection in a hemodialysis unit. A prospective study. Int. J. Artif. Organs 23:181-188.
89. Donahue, J. G., A. Munoz, P. M. Ness, D. E. Brown, Jr., D. H. Yawn, H. A. McAllister, Jr., B. A. Reitz, and K. E. Nelson. 1992. The declining risk of posttransfusion hepatitis C virus infection. N. Engl. J. Med. 327:369-373.
90. Duckworth, G. J., J. Heptonstall, and C. Aitken. 1999. Transmission of hepatitis C virus from a surgeon to a patient. The Incident Control Team. Commun. Dis. Public Health 2:188-192.
91. Dusheiko, G., H. Schmilovitz-Weiss, D. Brown, F. McOmish, P. L. Yap, S. Sherlock, N. McIntyre, and P. Simmonds. 1994. HCV genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology 19:13-18.
92. Dusheiko, G. M., M. Smith, and P. J. Scheuer. 1990. HCV transmitted by human bite. Lancet 336:503-504.
93. Echevarria, J. M., P. Leon, C. J. Domingo, J. A. Lopez, C. Elola, M. Madurga, F. Salmeron, P. L. Yap, J. Daub, and P. Simmonds. 1996. Laboratory diagnosis and molecular epidemiology of an outbreak of hepatitis C virus infection among recipients of human intravenous immunoglobulin in Spain. Transfusion 36:725-730.
94. Eckels, D. D., H. Wang, T. H. Bian, N. Tabatabai, and J. C. Gill. 2000. Immunobiology of hepatitis C virus (HCV) infection: the role of CD4 T-cells in HCV infection. Immunol. Rev. 174:90-97.
95. Einav, S., and M. J. Koziel. 2002. Immunopathogenesis of hepatitis C virus in the immunosuppressed host. Transpl. Infect. Dis. 4:85-92.
96. El-Serag, H. B., H. Hampel, C. Yeh, and L. Rabeneck. 2002. Extrahepatic manifestations of hepatitis C among United States male veterans. Hepatology 36:1439-1445.
97. Esteban, J. I., J. Gomez, M. Martell, B. Cabot, J. Quer, J. Camps, A. Gonzalez, T. Otero, A. Moya, R. Esteban, et al. 1996. Transmission of hepatitis C virus by a cardiac surgeon. N. Engl. J. Med. 334:555-560.
98. Esteve, M., I. Casas, R. Planas, and L. Matas. 2000. Accidental post inoculation of acute hepatitis C in a health care professional with response to interferon treatment. Med. Clin. (Barcelona) 114:157.
99. Fabrizi, F., P. Martin, V. Dixit, M. Brezina, M. J. Cole, S. Gerosa, M. Mousa, and G. Gitnick. 1998. Acquisition of hepatitis C virus in hemodialysis patients: a prospective study by branched DNA signal amplification assay. Am. J. Kidney Dis. 31:647-654.
100. Fabrizi, F., P. Martin, G. Lunghi, and C. Ponticelli. 2000. Nosocomial transmission of hepatitis C virus infection in hemodialysis patients: clinical perspectives. Int. J. Artif. Organs 23:805-816.
101. Fahey, B. J., D. E. Koziol, S. M. Banks, and D. K. Henderson. 1991. Frequency of nonparenteral occupational exposures to blood and body fluids before and after universal precautions training. Am. J. Med. 90:145-153.
102. Fanning, L., E. Kenny, M. Sheehan, B. Cannon, M. Whelton, J. O'Connell, J. K. Collins, and F. Shanahan. 1999. Viral load and clinicopathological features of chronic hepatitis C (lb) in a homogeneous patient population. Hepatology 29:904-907.
103. Fanning, L. J., J. Levis, E. Kenny-Walsh, F. Wynne, M. Whelton, and F. Shanahan. 2000. Viral clearance in hepatitis C (lb) infection: relationship with human leukocyte antigen class II in a homogeneous population. Hepatology 31:1334-1337.
104. Farci, P., H. J. Alter, S. Govindarajan, D. C. Wong, R. Engle, R. R. Lesniewski, I. K. Mushahwar, S. M. Desai, R. H. Miller, N. Ogata, et al. 1992. Lack of protective immunity against reinfection with hepatitis C virus. Science 258:135-140.
105. Farci, P., H. J. Alter, D. C. Wong, R. H. Miller, S. Govindarajan, R. Engle, M. Shapiro, and R. H. Purcell. 1994. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc. Natl. Acad. Sci. USA 91:7792-7796.
106. Farci, P., A. Shimoda, A. Coiana, G. Diaz, G. Peddis, J. C. Melpolder, A. Strazzera, D. Y. Chien, S. J. Munoz, A. Balestrieri, R. H. Purcell, and H. J. Alter. 2000. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 288:339-344.
107. Farci, P., A. Shimoda, D. Wong, T. Cabezon, D. De Gioannis, A. Strazzera, Y. Shimizu, M. Shapiro, H. J. Alter, and R. H. Purcell. 1996. Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proc. Natl. Acad. Sci. USA 93:15394-15399.
108. Farrugia, A., and E. Walker. 1995. HCV transmission by intravenous immunoglobulin. Lancet 346:373-375.
109. Feinstone, S. M., A. Z. Kapikian, R. H. Purcell, H. J. Alter, and P. V. Holland. 1975. Transfusion-associated hepatitis not due to viral hepatitis type A or B. N. Engl. J. Med. 292:767-770.
110. Figueiredo, J. F., A. S. Borges, R. Martinez, L. Martinelli Ade, M. G. Villanova, D. T. Covas, and A. D. Passas. 1994. Transmission of hepatitis C virus but not human immunodeficiency virus type 1 by a human bite. Clin. Infect. Dis. 19:546-547.
111. Filippini, P., N. Coppola, C. Scolastico, G. Rossi, M. Onofrio, E. Sagnelli, and F. Piccinino. 2001. Does HIV infection favor the sexual transmission of hepatitis C? Sex. Transm. Dis. 28:725-729.
112. Finlayson, J. S., and D. L. Tankersley. 1990. Anti-HCV screening and plasma fractionation: the case against. Lancet 335:1274-1275.
113. Fiore, R. J., D. Potenza, L. Monno, A. Appice, M. DiStefano, A. Giannelli, L. LaGrasta, C. Romanelli, C. DiBari, and G. Pastore. 1995. Detection of HCV RNA in serum and seminal fluid from HIV-1 coinfected intravenous drug addicts. J. Med. Virol. 46:364-367.
114. Flora, K., M. Schiele, K. Benner, A. Montanaro, W. Johnston, R. Whitham, and R. Press. 1996. An outbreak of acute hepatitis C among recipients of intravenous immunoglobulin. Ann. Allergy Asthma Immunol. 76:160-162.
115. Forns, X., J. Bukh, and R. H. Purcell. 2002. The challenge of developing a vaccine against hepatitis C virus. J. Hepatol. 37:684-695.
116. Francavilla, E., R. Rinaldi, A. M. Cattelan, M. Vicariotto, F. Bortolotti, and P. Cadrobbi. 1992. Low prevalence of antibodies to hepatitis C virus in hospital employees. Infection 20:295.
117. Frank, C., M. K. Mohamed, G. T. Strickland, D. Lavanchy, R. R. Arthur, L. S. Magder, T. El Khoby, Y. Abdel-Wahab, E. S. Aly Ohn, W. Anwar, and I. Sallam. 2000. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 355:887-891.
118. Freeman, A. J., G. Marinos, R. A. Ffrench, and A. R. Lloyd. 2001. Immunopathogenesis of hepatitis C virus infection. Immunol. Cell Biol. 79:515-536.
119. Fried, M. W. 2001. Advances in therapy for chronic hepatitis C. Clin. Liver Dis. 5:1009-1023.
120. Garces, J. M., H. Yazbeck, T. Pi-Sunyer, J. Gutierrez-Cebollada, and J. L. Lopez-Colomes. 1996. Simultaneous human immunodeficiency virus and Hepatitis C infection following a needle stick injury. Eur. J. Clin. Microbiol. Infect. Dis. 15:92-94.
121. Garner, J. S. 1996. Guideline for isolation precautions in hospitals. The Hospital Infection Control Practices Advisory Committee. Infect. Control Hosp. Epidemiol. 17:53-80.
122. Garson, J. A. 1994. The polymerase chain reaction and hepatitis C virus diagnosis. FEMS Microbiol. Rev. 14:229-239.
123. Gerberding, J. L. 1994. Incidence and prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and cytomegalovirus among health care personnel at risk for blood exposure: final report from a longitudinal study. J. Infect. Dis. 170:1410-1417.
124. Gerberding, J. L. 1999. Provider-to-patient HIV transmission: how to keep it exceedingly rare. Ann. Intern. Med. 130:64-65.
125. Gerberding, J. L., and D. K. Henderson. 1992. Management of occupational exposures to blood-borne pathogens: hepatitis B virus, hepatitis C virus, and human immunodeficiency virus. Clin. Infect. Dis. 14:1179-1185.
126. Gerlach, J. T., H. M. Diepolder, M. C. Jung, N. H. Gruener, W. W. Schraut, R. Zachoval, R. Hoffmann, C. A. Schirren, T. Santantonio, and G. R. Pape. 1999. Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C. Gastroenterology 117:933-941.
127. Gerlach, T. J., R. Zachoval, N. Gruener, M.-C. Jung, A. Ulsenheimer, W. Schraut, and A. Schirren. 2001. Acute hepatitis C: natural course and response to antiviral treatment. Hepatology 34:341.
128. Gomperts, E. D. 1994. HCV and Gammagard in France. Lancet 344:201.
129. Gordon, S. C., A. H. Patel, G. W. Kulesza, R. E. Barnes, and A. L. Silverman. 1992. Lack of evidence for the heterosexual transmission of hepatitis C. Am. J. Gastroenterol. 87:1849-1851.
130. Gretch, D., L. Corey, J. Wilson, C. dela Rosa, R. Willson, R. Carithers, Jr., M. Busch, J. Hart, M. Sayers, and J. Han. 1994. Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: high-titer viremia correlates with advanced stage of disease. J. Infect. Dis. 169:1219-1225.
131. Grethe, S., F. Gemsa, M. Monazahian, I. Bohme, A. Uy, and R. Thomssen. 2000. Molecular epidemiology of an outbreak of HCV in a hemodialysis unit: direct sequencing of HCV-HVR1 as an appropriate tool for phylogenetic analysis. J. Med. Virol. 60:152-158.
132. + T lymphocytes after infection with hepatitis C virus. J. Virol. 75:5550-5558.
133. Guidotti, L. G., and F. V. Chisari. 2001. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu. Rev. Immunol. 19:65-91.
134. Habib, M., M. K. Mohamed, F. Abdel-Aziz, L. S. Magder, M. Abdel-Hamid, F. Gamil, S. Madkour, N. N. Mikhail, W. Anwar, G. T. Strickland, A. D. Fix, and I. Sallam. 2001. HCV infection in a community in the Nile Delta: risk factors for seropositivity. Hepatology 33:248-253.
135. Haley, R. W., and R. P. Fischer. 2001. Commercial tattooing as a potentially important source of hepatitis C infection. Clinical epidemiology of 626 consecutive patients unaware of their hepatitis C serologic status. Medicine (Baltimore) 80:134-151.
136. Halfon, P., C. Roubicek, V. Gerolami, Y. Quentin, H. Khiri, G. Pepe, and Y. Berland. 2002. Use of phylogenetic analysis of hepatitis C virus (HCV) hypervariable region 1 sequences to trace an outbreak of HCV in an autodialysis unit. J. Clin. Microbiol. 40:1541-1545.
137. Hamid, S. S., B. Farooqui, Q. Rizvi, T. Sultana, and A. A. Siddiqui. 1999. Risk of transmission and features of hepatitis C after needle stick injuries. Infect. Control Hosp. Epidemiol. 20:63-64.
138. Hamory, B. H. 1983. Underreporting of needle stick injuries in a university hospital. Am. J. Infect. Control 11:174-177.
139. Harcourt, G., S. Hellier, M. Bunce, J. Satsangi, J. Collier, R. Chapman, R. Phillips, and P. Klenerman. 2001. Effect of HLA class II genotype on T helper lymphocyte responses and viral control in hepatitis C virus infection. J. Viral Hepatol. 8:174-179.
140. Hasan, F., H. Askar, J. Al Khalidi, M. Al Shamali, M. Al Kalaoui, and B. Al Nakib. 1999. Lack of transmission of hepatitis C virus following needle stick accidents. Hepatogastroenterology 46:1678-1681.
141. Healey, C., and H. Chapel. 1996. Intravenous immunoglobulin and hepatitis C virus: the British episode. Clin. Ther. 18:93-95.
142. Healey, C. J., N. K. Sabharwal, J. Daub, F. Davidson, P. L. Yap, K. A. Fleming, R. W. Chapman, P. Simmonds, and H. Chapel. 1996. Outbreak of acute hepatitis C following the use of anti-hepatitis C virus-screened intravenous immunoglobulin therapy. Gastroenterology 110:1120-1126.
143. Heinsen, A., F. Bendtsen, and A. Fomsgaard. 2000. A phylogenetic analysis elucidating a case of patient-to-patient transmission of hepatitis C virus during surgery. J. Hosp. Infect. 46:309-313.
144. Henderson, D. K. 2001. HIV postexposure prophylaxis in the 21st century. Emerg. Infect. Dis. 7:254-258.
145. Henderson, D. K. 1991. Post-exposure chemoprophylaxis for occupational exposure to HIV-1: current status and prospects for the future. Am. J. Med. 91:312S-319S.
146. Henderson, D. K., B. J. Fahey, M. E. Willy, J. M. Schmitt, K. Carey, and D. E. Koziol. 1990. Risk for occupational transmission of human immunodeficiency virus type 1 (HIV-1) associated with clinical exposures: a prospective evaluation. Ann. Intern. Med. 113:740-746.
147. Henderson, D. K., and J. L. Gerberding. 2002. Occupational and nonoccupational exposure management, p. 327-346. In R. Dolin, H. Masur, and M. S. Saag (ed.), AIDS therapy, 2nd ed. Churchill Livingstone, Philadelphia, Pa.
148. Henderson, D. K., A. J. Saah, B. J. Zak, R. A. Kaslow, H. C. Lane, T. Folks, W. C. Blackwelder, J. Schmitt, D. J. LaCamera, H. Masur, et al. 1986. Risk of nosocomial infection with human T-cell lymphotropic virus type III/lymphadenopathy-associated virus in a large cohort of intensively exposed health care workers. Ann. Intern. Med. 104:644-647.
149. Henderson, D. K., and the AIDS/Tuberculosis Subcommittee of the Society for Healthcare Epidemiology of America. 1997. Management of healthcare workers infected with hepatitis B virus, hepatitis C virus, human immunodeficiency virus, or other blood-borne pathogens. Infect. Control Hosp. Epidemiol. 18:349-363.
150. Henry, K., and S. Campbell. 1995. Needle stick/sharps injuries and HIV exposure among health care workers. National estimates based on a survey of U.S. hospitals. Minn. Med. 78:41-44.
151. Heptonstall, J. 2000. Surgeons who test positive for hepatitis C should be transferred to low risk duties. Rev. Med. Virol. 10:75-78.
152. Hernandez, M. E., M. Bruguera, T. Puyuelo, J. M. Barrera, J. M. Sanchez Tapias, and J. Rodes. 1992. Risk of needle stick injuries in the transmission of hepatitis C virus in hospital personnel. J. Hepatol. 16:56-58.
153. Hoey, J., and E. Wooltorton. 2001. Early treatment of acute hepatitis C infection may lead to cure. CMAJ 165:1527.
154. Hoofnagle, J. H. 2001. Therapy for acute hepatitis C. N. Engl. J. Med. 345:1495-1497.
155. Hoofnagle, J. H., and A. M. di Bisceglie. 1997. The treatment of chronic viral hepatitis. N. Engl. J. Med. 336:347-356.
156. Hutin, Y. J., P. Duclos, H. Hogerzeil, A. Ball, and R. Carr. 2002. Unsterile injections and emergence of human pathogens. Lancet 359:2280.
157. Hwang, S. J., S. D. Lee, R. H. Lu, C. W. Chu, J. C. Wu, S. T. Lai, and F. Y. Chang. 2001. Hepatitis C viral genotype influences the clinical outcome of patients with acute posttransfusion hepatitis C. J. Med. Virol. 65:505-509.
158. Ideo, G., and A. Bellobuono. 2002. New therapies for the treatment of chronic hepatitis C. Curr. Pharm. Des. 8:959-966.
159. Irish, D. N., C. Blake, J. Christophers, J. E. Craske, L. Burnapp, I. C. Abbs, E. M. MacMahon, P. Muir, J. E. Banatvala, and P. Simmonds. 1999. Identification of hepatitis C virus seroconversion resulting from nosocomial transmission on a haemodialysis unit: implications for infection control and laboratory screening. J. Med. Virol. 59:135-140.
160. Izopet, J., C. Pasquier, K. Sandres, J. Puel, and L. Rostaing. 1999. Molecular evidence for nosocomial transmission of hepatitis C virus in a French hemodialysis unit. J. Med. Virol. 58:139-144.
161. Jaeckel, E., M. Cornberg, H. Wedemeyer, T. Santantonio, J. Mayer, M. Zankel, G. Pastore, M. Dietrich, C. Trautwein, and M. P. Manns. 2001. Treatment of acute hepatitis C with interferon alfa-2b. N. Engl. J. Med. 345:1452-1457.
162. Jaeckel, E., and M. P. Manns. 2000. The course and therapy of acute hepatitis C viral infection. Is prevention of its becoming chronic possible? Z. Gastroenterol. 38:387-395.
163. James, R. C., and J. W. Mosley. 1995. HCV transmission by intravenous immunoglobulin. Lancet 346:374-375.
164. Jonas, M. M., M. J. Baron, J. S. Bresee, and L. C. Schneider. 1996. Clinical and virologic features of hepatitis C virus infection associated with intravenous immunoglobulin. Pediatrics 98:211-215.
165. Kagi, D., and H. Hengartner. 1996. Different roles for cytotoxic T-cells in the control of infections with cytopathic versus noncytopathic viruses. Curr. Opin. Immunol. 8:472-477.
166. Kao, J. H., and D. S. Chen. 2000. Transmission of hepatitis C virus in Asia: past and present perspectives. J. Gastroenterol. Hepatol. 15:E91-E96.
167. Kao, J. H., P. J. Chen, P. M. Yang, M. Y. Lai, J. C. Sheu, T. H. Wang, and D. S. Chen. 1992. Intrafamilial transmission of hepatitis C virus: the important role of infections between spouses. J. Infect. Dis. 166:900-903.
168. Kao, J. H., Y. T. Hwang, P. J. Chen, P. M. Yang, M. Y. Lai, T. H. Wang, and D. S. Chen. 1996. Transmission of hepatitis C virus between spouses: the important role of exposure duration. Am. J. Gastroenterol. 91:2087-2090.
169. Katayama, T., S. Kikuchi, Y. Tanaka, I. Saito, T. Miyamura, Q. L. Choo, M. Houghton, and G. Kuo. 1990. Blood screening for non-A, non-B hepatitis by hepatitis C virus antibody assay. Transfusion 30:374-376.
170. Katsoulidou, A., D. Paraskevis, V. Kalapothaki, D. Arvanitis, P. Karayiannis, V. Hadjiconstantiou, and A. Hatzakis. 1999. Molecular epidemiology of a hepatitis C virus outbreak in a haemodialysis unit. Multicentre Haemodialysis Cohort Study on Viral Hepatitis. Nephrol. Dial. Transplant. 14:1188-1194.
171. Kenny-Walsh, E. 1999. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group. N. Engl. J. Med. 340:1228-1233.
172. Kenny-Walsh, E. 2001. The natural history of hepatitis C virus infection. Clin. Liver Dis. 5:969-977.
173. Khan, A. J., S. P. Luby, F. Fikree, A. Karim, S. Obaid, S. Dellawala, S. Mirza, T. Malik, S. Fisher-Hoch, and J. B. McCormick. 2000. Unsafe injections and the transmission of hepatitis B and C in a periurban community in Pakistan. Bull. W.H.O. 78:956-963.
174. Kiyosawa, K., T. Sodeyama, E. Tanaka, Y. Nakano, S. Furuta, K. Nishioka, R. H. Purcell, and H. J. Alter. 1991. Hepatitis C in hospital employees with needle stick injuries. Ann. Intern. Med. 115:367-369.
175. Kjaergard, L. L., K. Krogsgaard, and C. Gluud. 2001. Interferon alfa with or without ribavirin for chronic hepatitis C: systematic review of randomised trials. Br. Med. J. 323:1151-1155.
176. Klenerman, P., F. Lechner, M. Kantzanou, A. Ciurea, H. Hengartner, and R. Zinkernagel. 2000. Viral escape and the failure of cellular immune responses. Science 289:0.2003.
177. Knodell, R. G., M. E. Conrad, A. L. Ginsberg, and C. J. Bell. 1976. Efficacy of prophylactic gamma-globulin in preventing non-A, non-B post-transfusion hepatitis. Lancet 1:557-561.
178. Knoll, A., M. Helmig, O. Peters, and W. Jilg. 2001. HCV transmission in a pediatric oncology ward: analysis of an outbreak and review of the literature. Lab. Investig. 81:251-262.
179. Ko, Y. C., M. S. Ho, T. A. Chiang, S. J. Chang, and P. Y. Chang. 1992. Tattooing as a risk of hepatitis C virus infection. J. Med. Virol. 38:288-291.
180. Koziel, M. J. 1997. The role of immune responses in the pathogenesis of hepatitis C virus infection. J. Viral Hepatol. 4:31-41.
181. Koziol, D. E., and D. K. Henderson. 1999. Nosocomial viral hepatitis in healthcare workers, p. 1057-1073. In C. G. Mayhall (ed.), Hospital epidemiology and infection control, 2nd ed. Lippincott, Williams and Wilkins, Philadelphia, Pa.
182. Krause, G., M. J. Trepka, R. S. Whisenhunt, D. Katz, O. Nainan, S. T. Wiersma, and R. S. Hopkins. 2003. Nosocomial transmission of hepatitis C virus associated with the use of multidose saline vials. Infect. Control Hosp. Epidemiol. 24:122-127.
183. Krawczynsld, K., M. J. Alter, D. L. Tankersley, M. Beach, B. H. Robertson, S. Lambert, G. Kuo, J. E. Spelbring, E. Meeks, S. Sinha, and D. A. Carson. 1996. Effect of immune globulin on the prevention of experimental hepatitis C virus infection. J. Infect. Dis. 173:822-828.
184. Kuo, G., Q. L. Choo, H. J. Alter, G. L. Gitnick, A. G. Redeker, R. H. Purcell, T. Miyamura, J. L. Dienstag, M. J. Alter, C. E. Stevens, et al. 1989. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244:362-364.
185. Reference deleted.
186. Lagging, L. M., C. Aneman, N. Nenonen, A. Brandberg, L. Grip, G. Norkrans, and M. Lindh. 2002. Nosocomial transmission of HCV in a cardiology ward during the window phase of infection: an epidemiological and molecular investigation. Scand. J. Infect. Dis. 34:580-582.
187. Lanphear, B. P., C. C. Linnemann, Jr., C. G. Cannon, M. M. DeRonde, L. Pendy, and L. M. Kerley. 1994. HCV infection in healthcare workers: risk of exposure and infection. Infect. Control Hosp. Epidemiol. 15:745-750.
188. Larghi, A., M. Zuin, A. Crosignani, M. L. Ribero, C. Pipia, P. M. Battezzati, G. Binelli, F. Donato, A. R. Zanetti, M. Podda, and A. Tagger. 2002. Outcome of an outbreak of acute hepatitis C among healthy volunteers participating in pharmacokinetics studies. Hepatology 36:993-1000.
189. Laskus, T., M. Radkowski, A. Bednarska, J. Wilkinson, D. Adair, M. Nowicki, G. B. Nikolopoulou, H. Vargas, and J. Rakela. 2002. Detection and analysis of hepatitis C virus sequences in cerebrospinal fluid. J. Virol. 76:10064-10068.
190. Lau, J. Y., M. Mizokami, J. A. Kolberg, G. L. Davis, L. E. Prescott, T. Ohno, R. P. Perrillo, K. L. Lindsay, R. G. Gish, K. P. Qian, et al. 1995. Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States. J. Infect. Dis. 171:281-289.
191. Lawlor, E., and G. Columb. 1999. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. N. Engl. J. Med. 341:762-763.
192. Lawlor, E., J. Power, J. Garson, P. Yap, F. Davidson, G. Columb, D. Smith, L. Pomeroy, J. O'Riordan, P. Simmonds, and R. Tedder. 1999. Transmission rates of hepatitis C virus by different batches of a contaminated anti-D immunoglobulin preparation. Vox Sang. 76:138-143.
193. Lechner, F., N. H. Gruener, S. Urbani, J. Uggeri, T. Santantonio, A. R. Kammer, A. Cerny, R. Phillips, C. Ferrari, G. R. Pape, and P. Klenerman. 2000. CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained. Eur. J. Immunol. 30:2479-2487.
194. Lechner, F., J. Sullivan, H. Spiegel, D. F. Nixon, B. Ferrari, A. Davis, B. Borkowsky, H. Pollack, E. Barnes, G. Dusheiko, and P. Klenerman. 2000. Why do cytotoxic T lymphocytes fail to eliminate hepatitis C virus? Lessons from studies using major histocompatibility complex class I peptide tetramers. Phil. Trans. R. Soc. Lond. B Biol. Sci. 355:1085-1092.
195. Lechner, F., D. K. Wong, P. R. Dunbar, R. Chapman, R. T. Chung, P. Dohrenwend, G. Robbins, R. Phillips, P. Klenerman, and B. D. Walker. 2000. Analysis of successful immune responses in persons infected with hepatitis C virus. J. Exp. Med. 191:1499-1512.
196. Lee, C., and G. Dusheiko. 2002. The natural history and antiviral treatment of hepatitis C in haemophilia. Haemophilia 8:322-329.
197. Lefrere, J. J., P. Loiseau, M. Martinot-Peignoux, M. Mariotti, N. Ravera, M. Thauvin, P. Marcellin, and C. Janot. 1996. Infection by hepatitis C virus through contaminated intravenous immune globulin: results of a prospective national inquiry in France. Transfusion 36:394-397.
198. Le Pogam, S., D. Le Chapois, R. Christen, F. Dubois, F. Barin, and A. Goudeau. 1998. Hepatitis C in a hemodialysis unit: molecular evidence for nosocomial transmission. J. Clin. Microbiol. 36:3040-3043.
199. Leruez-Ville, M., J. M. Kunstmann, M. De Almeida, C. Rouzioux, and M. L. Chaix. 2000. Detection of hepatitis C virus in the semen of infected men. Lancet 356:42-43.
200. Lesourd, F., J. Izopet, C. Mervan, J. L. Payen, K. Sandres, X. Monrozies, and J. Parinaud. 2000. Transmissions of hepatitis C virus during the ancillary procedures for assisted conception. Hum. Reprod. 15:1083-1085.
201. Liang, T. J., B. Rehermann, L. B. Seeff, and J. H. Hoofnagle. 2000. Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann. Intern. Med. 132:296-305.
202. Liou, T. C., T. T. Chang, K. C. Young, X. Z. Lin, C. Y. Lin, and H. L. Wu. 1992. Detection of HCV RNA in saliva, urine, seminal fluid, and ascites. J. Med. Virol. 37:197-202.
203. Macy, E. 1997. HCV and intravenous immune globulin. JAMA 277:627-628.
204. Maier, I., and G. Y. Wu. 2002. Hepatitis C and HIV coinfection: a review. World J. Gastroenterol. 8:577-579.
205. Mangione, C. M., J. L. Gerberding, and S. R. Cummings. 1991. Occupational exposure to HIV: frequency and rates of underreporting of percutaneous and mucocutaneous exposures by medical housestaff. Am. J. Med. 90:85-90.
206. Manns, M. P., J. G. McHutchison, S. C. Gordon, V. K. Rustgi, M. Shiffman, R. Reindollar, Z. D. Goodman, K. Koury, M. Ling, and J. K. Albrecht. 2001. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 358:958-965.
207. Manzin, A., M. Candela, L. Solforosi, A. Gabrielli, and M. Clementi. 1999. Dynamics of hepatitis C viremia after plasma exchange. J. Hepatol. 31:389-393.
208. Manzin, A., L. Solforosi, M. Debiaggi, F. Zara, E. Tanzi, L. Romano, A. R. Zanetti, and M. Clementi. 2000. Dominant role of host selective pressure in driving hepatitis C virus evolution in perinatal infection. J. Virol. 74:4327-4334.
209. Manzin, A., L. Solforosi, E. Petrelli, G. Macarri, G. Tosone, M. Piazza, and M. Clementi. 1998. Evolution of hypervariable region 1 of hepatitis C virus in primary infection. J. Virol. 72:6271-6276.
210. Marranconi, F., V. Mecenero, G. P. Pellizzer, M. C. Bettini, M. Conforto, A. Vaglia, C. Stecca, E. Cardone, and F. de Lalla. 1992. HCV infection after accidental needle stick injury in health-care workers. Infection 20:111.
211. Massari, M., N. Petrosillo, G. Ippolito, L. Solforosi, L. Bonazzi, M. Clementi, and A. Manzin. 2001. Transmission of hepatitis C virus in a gynecological surgery setting. J. Clin. Microbiol. 39:2860-2863.
212. McAllister, J., C. Casino, F. Davidson, J. Power, E. Lawlor, P. L. Yap, P. Simmonds, and D. B. Smith. 1998. Long-term evolution of the hypervariable region of hepatitis C virus in a common-source-infected cohort. J. Virol. 72:4893-4905.
213. McElborough, D., J. Paul, R. Hargreaves, J. C. Kingswood, K. Harris, and C. G. Teo. 2001. Possible cross-infection with hepatitis C virus of an unusual genotype on a haemodialysis unit. J. Hosp. Infect. 47:335-336.
214. McHutchison, J. G., and K. Patel. 2002. Future therapy of hepatitis C. Hepatology 36:S245-S252.
215. McKiernan, S., and D. Kelleher. 2000. Immunogenetics of hepatitis C virus. J. Viral Hepatol. 7:13-14.
216. Medhat, A., M. Shehata, L. S. Magder, N. Mikhail, L. Abdel-Baki, M. Nafeh, M. Abdel-Hamid, G. T. Strickland, and A. D. Fix. 2002. Hepatitis c in a community in Upper Egypt: risk factors for infection. Am. J. Trop. Med. Hyg. 66:633-638.
217. Mele, A., R. Corona, M. E. Tosti, F. Palumbo, A. Moiraghi, F. Novaco, C. Galanti, R. Bernacchia, and P. Ferraro. 1995. Beauty treatments and risk of parenterally transmitted hepatitis: results from the hepatitis surveillance system in Italy. Scand. J. Infect. Dis. 27:441-444.
218. Mele, A., E. Spada, L. Sagliocca, P. Ragni, M. E. Tosti, G. Gallo, A. Moiraghi, E. Balocchini, M. Sangalli, P. L. Lopalco, and T. Stroffoli. 2001. Risk of parenterally transmitted hepatitis following exposure to surgery or other invasive procedures: results from the hepatitis surveillance system in Italy. J. Hepatol. 35:284-289.
219. Memon, M. I., and M. A. Memon. 2002. Hepatitis C: an epidemiological review. J. Viral Hepatol. 9:84-100.
220. Mignogna, M. D., S. Fedele, L. Lo Russo, E. Ruoppo, D. Adamo, and L. Lo Muzio. 2002. Extrahepatic manifestations of HCV infection: the slowly unraveling picture of oral lichen planus. J. Hepatol. 37:412-413.
221. Miller, M. A., P. Orenstein, and B. Amihod. 1993. Administration of immune serum globulin following exposure to hepatitis C virus. Clin. Infect. Dis. 16:335.
222. Mitsui, T., K. Iwano, K. Masuko, C. Yamazaki, H. Okamoto, F. Tsuda, T. Tanaka, and S. Mishiro. 1992. HCV infection in medical personnel after needle stick accident. Hepatology 16:1109-1114.
223. Mizuno, Y., K. Suzuki, M. Mori, K. Hayashi, T. Owaki, H. Hayashi, K. Kumada, K. Ohba, and M. Mizokami. 1997. Study of needle stick accidents and hepatitis C virus infection in healthcare workers by molecular evolutionary analysis. J. Hosp. Infect. 35:149-154.
224. Morand, P., N. Dutertre, H. Minazzi, J. Burnichon, M. Pernollet, M. Baud, J. P. Zarski, and J. M. Seigneurin. 2001. Lack of seroconversion in a health care worker after polymerase chain reaction-documented acute hepatitis C resulting from a needle stick injury. Clin. Infect. Dis. 33:727-729.
225. Morsica, G., G. Sitia, M. T. Bernardi, G. Tambussi, R. Novati, A. De Bona, N. Gianotti, and A. Lazzarin. 2001. Acute self-limiting hepatitis C after possible sexual exposure: sequence analysis of the E-2 region of the infected patient and sexual partner. Scand. J. Infect. Dis. 33:116-120.
226. Mosley, J. W. 1997. HCV and intravenous immune globulin. JAMA 277:627-628.
227. Mujeeb, S. A. 2001. Unsafe injections: a potential source of HCV spread in Pakistan. J. Pak. Med. Assoc. 51:1-3.
228. Muscarella, L. F. 2001. Recommendations for preventing hepatitis C virus infection: analysis of a Brooklyn endoscopy clinic's outbreak. Infect. Control Hosp. Epidemiol. 22:669.
229. Nagao, Y., J. Tanaka, T. Nakanishi, T. Moriya, K. Katayama, J. Kumagai, Y. Komiya, Y. Itoh, Y. Myoken, M. Fujihara, M. Sata, and H. Yoshizawa. 2002. High incidence of extrahepatic manifestations in an HCV hyperendemic area. Hepatol. Res. 22:27-36.
230. Nakano, Y., K. Kiyosawa, T. Sodeyama, E. Tanaka, A. Matsumoto, T. Ichijo, M. Mizokami, and S. Furuta. 1995. Acute hepatitis C transmitted by needle stick accident despite short duration interferon treatment. J. Gastroenterol. Hepatol. 10:609-611.
231. Naoumov, N. V. 1999. HCV-specific CD4(+) T-cells: do they help or damage? Gastroenterology 117:1012-1014.
232. National Center for Health Statistics. 1994. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. DHHS Publication no. PHS 94-1308. Vital and Health Statistics, Series 1. Government Printing Office, Washington, D.C.
233. Nelson, D. R. 2001. The immunopathogenesis of hepatitis C virus infection. Clin. Liver Dis. 5:931-953.
234. Neumann, A. U., N. P. Lam, H. Dahari, D. R. Gretch, T. E. Wiley, T. J. Layden, and A. S. Perelson. 1998. Hepatitis C viral dynamics in vivo and the antiviral efficacy of alpha interferon therapy. Science 282:103-107.
235. Neumayr, G., A. Propst, H. Schwaighofer, G. Judmaier, and W. Vogel. 1999. Lack of evidence for the heterosexual transmission of hepatitis C. Q. J. Med. 92:505-508.
236. Nguyen, M. H., and T. L. Wright. 2001. Therapeutic advances in the management of hepatitis B and hepatitis C. Curr. Opin. Infect. Dis. 14:593-601.
237. Noguchi, S., M. Sata, H. Suzuki, K. Ohba, M. Mizokami, and K. Tanikawa. 1997. Early therapy with interferon for acute hepatitis C acquired through a needle stick. Clin. Infect. Dis. 24:992-994.
238. Norder, H., A. Bergstrom, I. Uhnoo, J. Alden, L. Weiss, J. Czajkowski, and L. Magnius. 1998. Confirmation of nosocomial transmission of hepatitis C virus by phylogenetic analysis of the NS5-B region. J. Clin. Microbiol. 36:3066-3069.
239. Nousbaum, J. B., S. Pol, B. Nalpas, P. Landais, P. Berthelot, and C. Brechot. 1995. HCV type 1b (II) infection in France and Italy. Collaborative Study Group. Ann. Intern. Med. 122:161-168.
240. Nubling, C. M., H. Willkommen, and J. Lower. 1995. Hepatitis C transmission associated with intravenous immunoglobulins. Lancet 345:1174.
241. Oketani, M., T. Higashi, N. Yamasaki, K. Shinmyozu, M. Osame, and T. Arima. 1999. Complete response to twice-a-day interferon-beta with standard alpha interferon therapy in acute hepatitis C after a needle stick. J. Clin. Gastroenterol. 28:49-51.
242. Oldach, D. 2002. Multidose jeopardy: HCV transmission risk and management of acute HCV in hospital settings. Hepatology 36:1020-1021.
243. Pawlotsky, J. M., F. Roudot-Thoraval, P. Simmonds, J. Mellor, M. B. Ben Yahia, C. Andre, M. C. Voisin, L. Intrator, E. S. Zafrani, J. Duval, et al. 1995. Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann. Intern. Med. 122:169-173.
244. Perez-Trallero, E., G. Cilla, and J. R. Saenz. 1994. Occupational transmission of HCV. Lancet 344:548.
245. Pessione, F., M. J. Ramond, C. Njapoum, V. Duchatelle, C. Degott, S. Erlinger, B. Rueff, D. C. Valla, and F. Degos. 2001. Cigarette smoking and hepatic lesions in patients with chronic hepatitis C. Hepatology 34:121-125.
246. Peters, M., G. L. Davis, J. S. Dooley, and J. H. Hoofnagle. 1986. The interferon system in acute and chronic viral hepatitis. Prog. Liver Dis. 8:453-467.
247. Petit, J. M., J. B. Bour, L. S. Aho, A. Castaneda, G. Vaillant, and J. M. Brun. 1999. HCV and diabetes mellitus: influence of nosocomial transmission with the use of a finger stick device. Am. J. Gastroenterol. 94:1709-1710.
248. Petrosillo, N., P. Gilli, D. Serraino, P. Dentico, A. Mele, P. Ragni, V. Puro, C. Casalino, and G. Ippolito. 2001. Prevalence of infected patients and understaffing have a role in hepatitis C virus transmission in dialysis. Am. J. Kidney Dis. 37:1004-1010.
249. Petrosillo, N., V. Puro, and G. Ippolito. 1994. Prevalence of hepatitis C antibodies in health-care workers. Italian Study Group on Blood-borne Occupational Risk in Dialysis. Lancet 344:339-340.
250. Piazza, M., L. Sagliocca, G. Tosone, V. Guadagnino, M. A. Stazi, R. Orlando, G. Borgia, D. Rosa, S. Abrignani, F. Palumbo, A. Manzin, and M. Clementi. 1997. Sexual transmission of the hepatitis C virus and efficacy of prophylaxis with intramuscular immune serum globulin. A randomized controlled trial. Arch. Intern. Med. 157:1537-1544.
251. Pilli, M., A. Penna, A. Zerbini, P. Vescovi, M. Manfredi, F. Negro, M. Carrozzo, C. Mori, T. Giuberti, C. Ferrari, and G. Missale. 2002. Oral lichen planus pathogenesis: A role for the HCV-specific cellular immune response. Hepatology 36:1446-1452.
252. Pimstone, N. R., J. S. Powell, R. Kotfila, D. J. Pimstone, and L. Davidson. 2000. High dose (780MIU/52 weeks) interferon monotherapy is highly effective treatment for acute hepatitis C. Gastroenterology 118:960.
253. + T-cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers. Proc. Natl. Acad. Sci. USA 94:6874-6879.
254. Pol, S., B. Lamorthe, N. T. Thi, V. Thiers, F. Carnot, H. Zylberberg, P. Berthelot, C. Brechot, and B. Nalpas. 1998. Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users. J. Hepatol. 28:945-950.
255. Poynard, T., V. Leroy, M. Cohard, T. Thevenot, P. Mathurin, P. Opolon, and J. P. Zarski. 1996. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration. Hepatology 24:778-789.
256. Pozzato, G., S. Kaneko, M. Moretti, L. S. Croce, F. Franzin, M. Unoura, L. Bercich, C. Tiribelli, M. Crovatto, G. Santini, et al. 1994. Different genotypes of hepatitis C virus are associated with different severity of chronic liver disease. J. Med. Virol. 43:291-296.
257. Pozzato, G., M. Moretti, F. Franzin, L. S. Croce, C. Tiribelli, T. Masayu, S. Kaneko, M. Unoura, and K. Kobayashi. 1991. Severity of liver disease with different hepatitis C viral clones. Lancet 338:509.
258. Prince, A. M. 1994. Challenges for development of hepatitis C virus vaccines. FEMS Microbiol. Rev. 14:273-277.
259. Public Health Laboratory Service. 2000. Hepatitis C look-back exercise. Commun. Dis. Rep. Wkly. 10:203, 206.
260. Public Health Laboratory Service. 31 October 2002, posting date. Hepatitis C look-back in two Trusts in the south of England. Public Health Laboratory Service vol. 12(34). (Online.)
261. Public Health Laboratory Service. 1995. HCV transmission from health care worker to patient. Commun. Dis. Rep. Wkly. 5:121.
262. Public Health Laboratory Service. 22 August 2002, posting date. New guidance on hepatitis C infected health care workers. Public Health Laboratory Service vol. 12(34). (Online.)
263. Public Health Laboratory Service. 1999. Transmission of hepatitis C virus from surgeon to patient prompts look-back. Commun. Dis. Rep. Wkly. 9:387.
264. Public Health Laboratory Service. 2000. Two hepatitis C look-back exercises - national and in London. Commun. Dis. Rep. Wkly. 10:125, 128.
265. Pugliese, G., and M. S. Favero. 2000. Healthcare worker-to-patient transmission of HCV in the United Kingdom. Infect. Control Hosp. Epidemiol. 21:619.
266. Puoti, C., R. Castellacci, and F. Montagnese. 2000. HCV carriers with persistently normal aminotransferase levels: healthy people or true patients? Dig. Liver Dis. 32:634-643.
267. Puro, V., G. De Carli, P. Scognamiglio, R. Porcasi, and G. Ippolito. 2001. Risk of HIV and other blood-borne infections in the cardiac setting: patient-to-provider and provider-to-patient transmission. Ann. N. Y. Acad. Sci. 946:291-309.
268. Puro, V., N. Petrosillo, G. Ippolito, M. Aloisi, E. Boumis, L. Ravà, and the Italian Study Group on Occupational Risk of Blood-Borne Infections. 1995. Occupational hepatitis C virus infection in Italian health care workers. Am. J. Public Health 85:1272-1275.
269. Puro, V., N. Petrosillo, G. Ippolito, and Italian Study Group on Occupational Risk of H. I. V. and Other Blood-borne Infections. 1995. Risk of hepatitis C seroconversion after occupational exposures in health care workers. Am. J. Infect. Control 23:273-277.
270. Puro, V., N. Petrosillo, G. Ippolito, and J. Jagger. 1995. HCV infection in healthcare workers. Infect. Control Hosp. Epidemiol. 16:324-326.
271. Qu, D., J. S. Li, L. Vitvitski, S. Mechai, F. Berby, S. P. Tong, F. Bailly, Q. S. Wang, J. L. Martin, and C. Trepo. 1994. HCV genotypes in France: comparison of clinical features of patients infected with HCV type I and type II. J. Hepatol. 21:70-75.
272. Quinti, I., F. Pandolfi, R. Paganelli, A. Giovannetti, G. Sacco, A. Oliva, and F. Aiuti. 1996. HCV infection in Italian patients with hypogammaglobulinemia. Clin. Ther. 18:96-107.
273. Rao, M. R., A. B. Naficy, M. A. Darwish, N. M. Darwish, E. Schisterman, J. D. Clemens, and R. Edelman. 2002. Further evidence for association of hepatitis C infection with parenteral schistosomiasis treatment in Egypt. BMC Infect. Dis. 2:29.
274. Ray, R., A. Khanna, L. M. Lagging, K. Meyer, Q. L. Choo, R. Ralston, M. Houghton, and P. R. Becherer. 1994. Peptide immunogen mimicry of putative E1 glycoprotein-specific epitopes in hepatitis C virus. J. Virol. 68:4420-4426.
275. Ray, S. C., Y. M. Wang, O. Laeyendecker, J. R. Ticehurst, S. A. Villano, and D. L. Thomas. 1999. Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: hypervariable region 1 as a decoy. J. Virol. 73:2938-2946.
276. Razvi, S., L. Schneider, M. M. Jonas, and C. Cunningham-Rundles. 2001. Outcome of intravenous immunoglobulin-transmitted hepatitis C virus infection in primary immunodeficiency. Clin. Immunol. 101:284-288.
277. Regez, R. M., P. J. Rietra, C. T. van der Linden, P. H. Frissen, H. M. Weigel, and K. Brinkman. 2002. Reducing the risk of blood-transmitted infections of HIV, hepatitis B or C virus in a teaching hospital in Amsterdam - evaluation of a protocol for needle stick accidents among hospital staff during the period 1997-2001. Ned. Tijdschr. Geneeskd. 146:617-621.
278. Rehermann, B. 1999. Cellular immune response to the hepatitis C virus. J. Viral Hepatol. 6:31-35.
279. Rehermann, B. 1996. Immunopathogenesis of viral hepatitis. Baillieres Clin. Gastroenterol. 10:483-500.
280. Rehermann, B. 2000. Interaction between the hepatitis C virus and the immune system. Semin. Liver Dis. 20:127-141.
281. Rehermann, B., and F. V. Chisari. 2000. Cell mediated immune response to the hepatitis C virus. Curr. Top. Microbiol. Immunol. 242:299-325.
282. Ridzon, R., K. Gallagher, C. Ciesielski, M. B. Ginsberg, B. J. Robertson, C. C. Luo, and A. DeMaria, Jr. 1997. Simultaneous transmission of human immunodeficiency virus and hepatitis C virus from a needle stick injury. N. Engl. J. Med. 336:919-922.
283. Romeo, R., M. G. Rumi, E. Del Ninno, and M. Colombo. 1997. HCV genotype 1b and risk of hepatocellular carcinoma. Hepatology 26:1077.
284. Rosen, H. R. 1997. Acquisition of hepatitis C by a conjunctival splash. Am. J Infect. Control 25:242-247.
285. Ross, R. S., S. Viazov, T. Gross, F. Hofmann, H. M. Seipp, and M. Roggendorf. 2000. Transmission of hepatitis C virus from a patient to an anesthesiology assistant to five patients. N. Engl. J. Med. 343:1851-1854.
286. Ross, R. S., S. Viazov, and M. Roggendorf. 2002. Phylogenetic analysis indicates transmission of hepatitis C virus from an infected orthopedic surgeon to a patient. J. Med. Virol. 66:461-467.
287. Ross, R. S., S. Viazov, M. Thormahlen, L. Bartz, J. Tamm, P. Rautenberg, M. Roggendorf, and A. Deister. 2002. Risk of hepatitis C virus transmission from an infected gynecologist to patients: results of a 7-year retrospective investigation. Arch. Intern. Med. 162:805-810.
288. Rossi, G., A. Tucci, E. Cariani, A. Ravaggi, A. Rossini, and E. Radaeli. 1997. Outbreak of hepatitis C virus infection in patients with hematologic disorders treated with intravenous immunoglobulins: different prognosis according to the immune status. Blood 90:1309-1314.
289. Ruibal Brunet, I. J., E. Noa Romero, A. T. Rivero Mas, and R. Z. Martin Garcia. 1999. Inactivation of BVDV (experimental model for hepatitis C) using low pH and heat treatment in intravenous human immunoglobulins. Sangre (Barcelona) 44:352-356.
290. Saginur, R., J. Nixon, B. Devries, N. Bruce, C. Carruthers, L. Scully, R. Berger, J. Leech, L. Nicolle, and A. Mackenzie. 2001. Transmission of hepatitis C in a pharmacologic study. Infect. Control Hosp. Epidemiol. 22:697-700.
291. Sanchez-Quijano, A., J. A. Pineda, E. Lissen, M. Leal, M. A. Diaz-Torres, F. Garcia De Pesquera, F. Rivera, R. Castro, and J. Munoz. 1988. Prevention of post-transfusion non-A, non-B hepatitis by non-specific immunoglobulin in heart surgery patients. Lancet 1:1245-1249.
292. Sanchez-Tapias, J. M. 1999. Nosocomial transmission of hepatitis C virus. J. Hepatol. 31:107-112.
293. Sartori, M., G. La Terra, M. Aglietta, A. Manzin, C. Navino, and G. Verzetti. 1993. Transmission of hepatitis C via blood splash into conjunctiva. Scand. J. Infect. Dis. 25:270-271.
294. Sata, M., T. Ide, S. Noguchi, O. Hashimoto, R. Kumashiro, H. Suzuki, and K. Tanikawa. 1997. Timing of IFN therapy initiation for acute hepatitis C after accidental needle stick. J. Hepatol. 27:425-426.
295. Schiff, E. R. 1992. Hepatitis C among health care providers: risk factors and possible prophylaxis. Hepatology 16:1300-1301.
296. Schiff, E. R. 1997. Hepatitis C and alcohol. Hepatology 26:39S-42S.
297. Schlipkoter, U., M. Roggendorf, K. Cholmakow, A. Weise, and F. Deinhardt. 1990. Transmission of hepatitis C virus (HCV) from a haemodialysis patient to a medical staff member. Scand. J. Infect. Dis. 22:757-758.
298. Schneider, L. C., M. M. Jonas, M. J. Baron, E. F. Mast, M. J. Alter, L. B. Schonberger, S. Lambert, P. Coleman, and J. S. Bresee. 1996. Intravenous immunoglobulin and hepatitis C virus: the Boston episode. Clin. Ther. 18:108-109.
299. Schvarcz, R., B. Johansson, B. Nystrom, and A. Sonnerborg. 1997. Nosocomial transmission of hepatitis C virus. Infection 25:74-77.
300. Seeff, L. B. 1991. Hepatitis C from a needle stick injury. Ann. Intern. Med. 115:411.
301. Seeff, L. B. 1997. Natural history of hepatitis C. Hepatology 26:21S-28S.
302. Seeff, L. B. 1998. The natural history of hepatitis C-A quandary. Hepatology 28:1710-1712.
303. Seeff, L. B., F. B. Hollinger, H. J. Alter, E. C. Wright, C. M. Cain, Z. J. Buskell, K. G. Ishak, F. L. Iber, D. Toro, A. Samanta, R. L. Koretz, R. P. Perrillo, Z. D. Goodman, R. G. Knodell, G. Gitnick, T. R. Morgan, E. R. Schiff, S. Lasky, C. Stevens, R. Z. Vlahcevic, E. Weinshel, T. Tanwandee, H. J. Lin, and L. Barbosa. 2001. Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: a National Heart, Lung, and Blood Institute collaborative study. Hepatology 33:455-463.
304. Seeff, L. B., and J. H. Hoofnagle. 2002. National Institutes of Health Consensus Development Conference: management of hepatitis C, 2002. Hepatology 36:S1-S2.
305. Seeff, L. B., R. N. Miller, C. S. Rabkin, Z. Buskell-Bales, K. D. Straley-Eason, B. L. Smoak, L. D. Johnson, S. R. Lee, and E. L. Kaplan. 2000. 45-year follow-up of hepatitis C virus infection in healthy young adults. Ann. Intern. Med. 132:105-111.
306. Seeff, L. B., E. C. Wright, H. J. Zimmerman, H. J. Alter, et al. 1978. Type B hepatitis after needle stick exposure: prevention with hepatitis B immune globulin. Final report of the Veterans Administration Cooperative Study. Ann. Intern. Med. 88:285-293.
307. Seeff, L. B., H. J. Zimmerman, E. C. Wright, J. D. Finkelstein, P. Garcia-Pont, H. B. Greenlee, A. A. Dietz, C. M. Leevy, C. H. Tamburro, E. R. Schiff, E. M. Schimmel, R. Zemel, D. S. Zimmon, and R. W. McCollum. 1977. A randomized, double blind controlled trial of the efficacy of immune serum globulin for the prevention of post-transfusion hepatitis. A Veterans Administration cooperative study. Gastroenterology 72:111-121.
308. Sermoneta-Gertel, S., M. Donchin, R. Adler, M. Baras, T. Perlstein, N. Manny, D. Shouval, and E. Galun. 2001. Hepatitis c virus infection in employees of a large university hospital in Israel. Infect. Control Hosp. Epidemiol. 22:754-761.
309. Serra, C., M. Torres, and M. Campins. 1998. Occupational risk of hepatitis C virus infection after accidental exposure. Catalonia Group for the Study of the Occupational Risk of HCV Infection at Hospitals. Med. Clin (Barcelona) 111:645-649.
310. Shapiro, C. N. 1995. Occupational risk of infection with hepatitis B and hepatitis C virus. Surg. Clin. North Am. 75:1047-1056.
311. Shin, H. R., J. Y. Kim, J. I. Kim, D. H. Lee, K. Y. Yoo, D. S. Lee, and S. Franceschi. 2002. Hepatitis B and C virus prevalence in a rural area of South Korea: the role of acupuncture. Br. J. Cancer 87:314-318.
312. Silini, E., A. Locasciulli, L. Santoleri, L. Gargantini, G. Pinzello, M. Montillo, L. Foti, A. Lisa, N. Orfeo, E. Magliano, A. Nosari, and E. Morra. 2002. HCV infection in a hematology ward: evidence for nosocomial transmission and impact on hematologic disease outcome. Haematologica 87:1200-1208.
313. Silverman, A. L., J. E. Puccio, G. W. Kulesza, D. G. McCray, and S. C. Gordon. 1994. HCV RNA is present in the menstrual blood of women with chronic hepatitis C infection. Am. J. Gastroenterol. 89:1201-1202.
314. Simmonds, P. 1995. Variability of hepatitis C virus. Hepatology 21:570-583.
315. Simmonds, P., A. Alberti, H. J. Alter, F. Bonino, D. W. Bradley, C. Brechot, J. T. Brouwer, S. W. Chan, K. Chayama, D. S. Chen, et al. 1994. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 19:1321-1324.
316. Sivapalasingam, S., S. F. Malak, J. F. Sullivan, J. Lorch, and K. A. Sepkowitz. 2002. High prevalence of hepatitis C infection among patients receiving hemodialysis at an urban dialysis center. Infect. Control Hosp. Epidemiol. 23:319-324.
317. Smith, D. B., E. Lawlor, J. Power, J. O'Riordan, J. McAllister, C. Lycett, F. Davidson, S. Pathirana, J. A. Garson, R. S. Tedder, P. L. Yap, and P. Simmonds. 1999. A second outbreak of hepatitis C virus infection from anti-D immunoglobulin in Ireland. Vox Sang. 76:175-180.
318. Sodeyama, T., K. Kiyosawa, A. Urushihara, A. Matsumoto, E. Tanaka, S. Furuta, and Y. Akahane. 1993. Detection of hepatitis C virus markers and hepatitis C virus genomic-RNA after needle stick accidents. Arch. Intern. Med. 153:1565-1572.
319. Soto, B., A. Sanchez-Quijano, L. Rodrigo, J. A. del Olmo, M. Garcia-Bengoechea, J. Hernandez-Quero, C. Rey, M. A. Abad, M. Rodriguez, M. Sales Gilabert, F. Gonzalez, P. Miron, A. Caruz, F. Relimpio, R. Torronteras, M. Leal, and E. Lissen. 1997. Human immunodeficiency virus infection modifies the natural history of chronic parenterally acquired hepatitis C with an unusually rapid progression to cirrhosis. J. Hepatol. 26:1-5.
320. Stellini, R., A. Calzini, A. Gussago, A. Rodella, and A. Signorini. 1993. Low prevalence of anti-HCV antibodies in hospital workers. Eur. J. Epidemiol. 9:674-675.
321. Stroffolini, T., U. Lorenzoni, F. Menniti-Ippolito, D. Infantolino, and M. Chiaramonte. 2001. HCV infection in spouses: sexual transmission or common exposure to the same risk factors? Am. J. Gastroenterol. 96:3138-3141.
322. Stroffolini, T., A. Marzolini, F. Palumbo, F. Novaco, A. Moiraghi, E. Balocchini, R. Bernacchia, R. Corona, and A. Mele. 1996. Incidence of non-A, non-B and HCV positive hepatitis in healthcare workers in Italy. J. Hosp. Infect. 33:131-137.
323. Stuyver, L., R. Rossau, A. Wyseur, M. Duhamel, B. Vanderborght, H. Van Heuverswyn, and G. Maertens. 1993. Typing of hepatitis C virus isolates and
324. Sulkowski, M. S., E. E. Mast, L. B. Seeff, and D. L. Thomas. 2000. HCV infection as an opportunistic disease in persons infected with human immunodeficiency virus. Clin. Infect. Dis. 30:S77-84.
325. Sulkowski, M. S., S. C. Ray, and D. L. Thomas. 2002. Needle stick transmission of hepatitis C. JAMA 287:2406-2413.
326. Sullivan, D. G., S. S. Kim, J. J. Wilson, C. Stehman-Breen, and D. R. Gretch. 2001. Investigating hepatitis C virus heterogeneity in a high prevalence setting using heteroduplex tracking analysis. J. Virol. Methods 96:5-16.
327. Sun, C. A., H. C. Chen, C. F. Lu, S. L. You, Y. C. Mau, M. S. Ho, S. H. Lin, and C. J. Chen. 1999. Transmission of hepatitis C virus in Taiwan: prevalence and risk factors based on a nationwide survey. J. Med. Virol. 59:290-296.
328. Sun, C. A., H. C. Chen, S. N. Lu, C. J. Chen, C. F. Lu, S. L. You, and S. H. Lin. 2001. Persistent hyperendemicity of hepatitis C virus infection in Taiwan: the important role of iatrogenic risk factors. J. Med. Virol. 65:30-34.
329. Sun, D. X., F. G. Zhang, Y. Q. Geng, and D. S. Xi. 1996. Hepatitis C transmission by cosmetic tattooing in women. Lancet 347:541.
330. Suzuki, K., M. Mizokami, J. Y. Lau, N. Mizoguchi, K. Kato, Y. Mizuno, T. Sodeyama, K. Kiyosawa, and T. Gojobori. 1994. Confirmation of hepatitis C virus transmission through needle stick accidents by molecular evolutionary analysis. J. Infect. Dis. 170:1575-1578.
331. Takagi, H., M. Uehara, S. Kakizaki, H. Takahashi, J. Takezawa, K. Kabeya, K. Satoh, A. Kojima, S. Saito, T. Matsumoto, Y. Hashimoto, T. Abe, T. Yamada, K. Konaka, R. Shimoda, H. Takayama, K. Takehara, T. Nagamine, and M. Mori. 1998. Accidental transmission of HCV and treatment with interferon. J. Gastroenterol. Hepatol. 13:238-243.
332. Takaki, A., M. Wiese, G. Maertens, E. Depla, U. Seifert, A. Liebetrau, J. L. Miller, M. P. Manns, and B. Rehermann. 2000. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat. Med. 6:578-582.
333. Taskapan, H., O. Oymak, A. Dogukan, and C. Utas. 2001. Patient to patient transmission of hepatitis C virus in hemodialysis units. Clin. Nephrol. 55:477-481.
334. Thevenot, T., C. Regimbeau, V. Ratziu, V. Leroy, P. Opolon, and T. Poynard. 2001. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 update. J. Viral Hepatol. 8:48-62.
335. Thimme, R., D. Oldach, K. M. Chang, C. Steiger, S. C. Ray, and F. V. Chisarl. 2001. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J. Exp. Med. 194:1395-1406.
336. Thomas, D. L. 2001. Hepatitis C. Epidemiologic quandaries. Clin. Liver Dis. 5:955-968.
337. Thomas, D. L., J. Astemborski, R. M. Rai, F. A. Anania, M. Schaeffer, N. Galai, K. Nolt, K. E. Nelson, S. A. Strathdee, L. Johnson, O. Laeyendecker, J. Boitnott, L. E. Wilson, and D. Vlahov. 2000. The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA 284:450-456.
338. Thomas, D. L., R. O. Cannon, C. N. Shapiro, E. W. Hook, 3rd, M. J. Alter, and T. C. Quinn. 1994. Hepatitis C, hepatitis B, and human immunodeficiency virus infections among non-intravenous drug-using patients attending clinics for sexually transmitted diseases. J. Infect. Dis. 169:990-995.
339. Thomas, D. L., J. W. Shih, H. J. Alter, D. Vlahov, S. Cohn, D. R. Hoover, L. Cheung, and K. E. Nelson. 1996. Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users. J. Infect. Dis. 174:690-695.
340. Thomas, D. L., J. M. Zenilman, H. J. Alter, J. W. Shih, N. Galai, A. V. Carella, and T. C. Quinn. 1995. Sexual transmission of hepatitis C virus among patients attending sexually transmitted diseases clinics in Baltimore - an analysis of 309 sex partnerships. J. Infect. Dis. 171:768-775.
341. Thomsen, A. R., J. Johansen, O. Marker, and J. P. Christensen. 1996. Exhaustion of CTL memory and recrudescence of viremia in lymphocytic choriomeningitis virus-infected MHC class II-deficient mice and B cell-deficient mice. J. Immunol. 157:3074-3080.
342. Thomsen, A. R., A. Nansen, C. Andersen, J. Johansen, O. Marker, and J. P. Christensen. 1997. Cooperation of B cells and T-cells is required for survival of mice infected with vesicular stomatitis virus. Int. Immunol. 9:1757-1766.
343. Thomson, M., M. Nascimbeni, M. B. Havert, M. Major, S. Gonzales, H. Alter, S. M. Feinstone, K. K. Murthy, B. Rehermann, and T. J. Liang. 2003. The clearance of hepatitis C virus infection in chimpanzees may not necessarily correlate with the appearance of acquired immunity. J. Virol. 77:862-870.
344. Thursz, M., R. Yallop, R. Goldin, C. Trepo, and H. C. Thomas. 1999. Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research. Lancet 354:2119-2124.
345. Tokars, J. I., M. J. Arduino, and M. J. Alter. 2001. Infection control in hemodialysis units. Infect. Dis. Clin. North Am. 15:797-812, viii.
346. Tokars, J. I., M. Frank, M. J. Alter, and M. J. Arduino. 2002. National surveillance of dialysis-associated diseases in the United States, 2000. Semin. Dial. 15:162-171.
347. Toyoda, H., H. Sakamoto, T. Mizuno, Y. Horiguchi, and H. Nakano. 2000. Eradication of hepatitis C virus lb by interferon in a health care worker with acute hepatitis following needle stick transmission from a patient with chronic hepatitis C unresponsive to interferon. Scand. J. Gastroenterol. 35:1117-1120.
348. Trasancos, C. C., M. A. Kainer, P. V. Desmond, and H. Kelly. 2001. Investigation of potential iatrogenic transmission of hepatitis C in Victoria, Australia. Aust. N. Z. J. Public Health 25:241-244.
349. Tsude, K., S. Fujiyama, S. Sato, S. Kawano, Y. Taura, K. Yoshida, and T. Sato. 1992. Two cases of accidental transmission of hepatitis C to medical staff. Hepatogastroenterology 39:73-75.
350. Tumminelli, F., P. Marcellin, S. Rizzo, S. Barbera, G. Corvino, P. Furia, J. P. Benhamou, and S. Erlinger. 1995. Shaving as potential source of hepatitis C virus infection. Lancet 345:658.
351. Vaqlia, A., R. Nicolin, V. Puro, G. Ippolito, C. Bettini, and F. de Lalla. 1990. Needle stick hepatitis C virus seroconversion in a surgeon. Lancet 336:1315-1316.
352. Vento, S., and F. Cainelli. 2002. Does hepatitis C virus cause severe liver disease only in people who drink alcohol? Lancet Infect. Dis. 2:303-309.
353. Villano, S. A., D. Vlahov, K. E. Nelson, S. Cohn, and D. L. Thomas. 1999. Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection. Hepatology 29:908-914.
354. Vogel, W. 1999. Treatment of acute hepatitis C virus infection. J. Hepatol. 31:189-192.
355. Vogel, W., I. Graziadei, F. Umlauft, C. Datz, F. Hackl, S. Allinger, K. Grunewald, and J. Patsch. 1996. High-dose alpha interferon-α2b treatment prevents chronicity in acute hepatitis C: a pilot study. Dig. Dis. Sci. 41:81S-85S.
356. Vrielink, H., C. L. van der Poel, H. W. Reesink, H. L. Zaaijer, E. Scholten, L. C. Kremer, H. T. Cuypers, P. N. Lelie, and M. H. van Oers. 1995. Look-back study of infectivity of anti-HCV ELISA-positive blood components. Lancet 345:95-96.
357. Wang, C. S., S. T. Wang, T. T. Chang, W. J. Yao, and P. Chou. 2002. Smoking and alanine aminotransferase levels in hepatitis C virus infection: implications for prevention of hepatitis C virus progression. Arch. Intern. Med. 162:811-815.
358. Wang, T. Y., H. T. Kuo, L. C. Chen, Y. T. Chen, C. N. Lin, and M. M. Lee. 2002. Use of polymerase chain reaction for early detection and management of hepatitis C virus infection after needle stick injury. Ann. Clin. Lab. Sci. 32:137-141.
359. Wang, Y. S., S. Youngster, M. Grace, J. Bausch, R. Bordens, and D. F. Wyss. 2002. Structural and biological characterization of pegylated recombinant interferon alpha-2b and its therapeutic implications. Adv. Drug Deliv. Rev. 54:547-570.
360. Ward, S., G. Lauer, R. Isba, B. Walker, and P. Klenerman. 2002. Cellular immune responses against hepatitis C virus: the evidence base 2002. Clin. Exp. Immunol. 128:195-203.
361. Wasley, A., and M. J. Alter. 2000. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin. Liver Dis. 20:1-16.
362. Wedemeyer, H., X. S. He, M. Nascimbeni, A. R. Davis, H. B. Greenberg, J. H. Hoofnagle, T. J. Liang, H. Alter, and B. Rehermann. 2002. Impaired effector function of hepatitis C virus-specific CD8+ T-cells in chronic hepatitis C virus infection. J. Immunol. 169:3447-3458.
363. Wejstal, R. 1999. Sexual transmission of hepatitis C virus. J. Hepatol. 31:92-95.
364. Werner, B. G., and G. F. Grady. 1982. Accidental hepatitis-B-surface-antigen-positive inoculations. Use of e antigen to estimate infectivity. Ann. Intern. Med. 97:367-369.
365. Widell, A., B. Christensson, T. Wiebe, C. Schalen, H. B. Hansson, T. Allander, and M. A. Persson. 1999. Epidemiologic and molecular investigation of outbreaks of hepatitis C virus infection on a pediatric oncology service. Ann. Intern. Med. 130:130-134.
366. Wreghitt, T. G. 1999. Blood-borne virus infections in dialysis units - a review. Rev. Med. Virol. 9:101-109.
367. Wreghitt, T. G., J. J. Gray, J. P. Allain, J. Poulain, J. A. Garson, R. Deaville, C. Maple, J. Parameshwar, R. Y. Calne, J. Wallwork, et al. 1994. Transmission of hepatitis C virus by organ transplantation in the United Kingdom. J. Hepatol. 20:768-772.
368. Yamada, M., S. Kakumu, K. Yoshioka, Y. Higashi, K. Tanaka, T. Ishikawa, and M. Takayanagi. 1994. HCV genotypes are not responsible for development of serious liver disease. Dig. Dis. Sci. 39:234-239.
369. Yap, P. L. 1996. Intravenous immunoglobulin and hepatitis C virus: an overview of transmission episodes with emphasis on manufacturing data. Clin. Ther. 18:43-58.
370. Yap, P. L., F. McOmish, A. D. Webster, L. Hammarstrom, C. I. Smith, J. Bjorkander, H. D. Ochs, S. H. Fischer, I. Quinti, and P. Simmonds. 1994. HCV transmission by intravenous immunoglobulin. J. Hepatol. 21:455-460.
371. Yerly, S., R. Quadri, F. Negro, K. P. Barbe, J. J. Cheseaux, P. Burgisser, C. A. Siegrist, and L. Perrin. 2001. Nosocomial outbreak of multiple blood-borne viral infections. J. Infect. Dis. 184:369-372.
372. Young, K. C., T. T. Chang, T. C. Liou, and H. L. Wu. 1993. Detection of hepatitis C virus RNA in peripheral blood mononuclear cells and in saliva. J. Med. Virol. 41:55-60.
373. Yu, M. W. 1996. Follow-up studies of hepatitis C association with an intravenous immunoglobulin. Dev. Biol. Stand. 88:215-216.
374. Zaaijer, H. L., H. T. Cuypers, H. W. Reesink, I. N. Winkel, G. Gerken, and P. N. Lelie. 1993. Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet 341:722-724.
375. Zegans, M. E., W. Anninger, C. Chapman, and S. R. Gordon. 2002. Ocular manifestations of hepatitis C virus infection. Curr. Opin. Ophthalmol. 13:423-427.
376. Zibert, A., P. Dudziak, E. Schreier, and M. Roggendorf. 1997. Characterization of antibody response to hepatitis C virus protein E2 and significance of hypervariable region 1-specific antibodies in viral neutralization. Arch. Virol. 142:523-534.
377. Zibert, A., W. Kraas, H. Meisel, G. Jung, and M. Roggendorf. 1997. Epitope mapping of antibodies directed against hypervariable region 1 in acute self-limiting and chronic infections due to hepatitis C virus. J. Virol. 71:4123-4127.
378. Zibert, A., H. Meisel, W. Kraas, A. Schulz, G. Jung, and M. Roggendorf. 1997. Early antibody response against hypervariable region 1 is associated with acute self-limiting infections of hepatitis C virus. Hepatology 25:1245-1249.
379. Zoulim, F., M. Chevallier, M. Maynard, and C. Trepo. 2003. Clinical consequences of hepatitis C virus infection. Rev. Med. Virol. 13:57-68.
380. Zuckerman, J., G. Clewley, P. Griffiths, and A. Cockcroft. 1994. Prevalence of hepatitis C antibodies in clinical health-care workers. Lancet 343:1618-1620.